Publication:
Leishmania Hijacks Myeloid Cells for Immune Escape

dc.contributor.authorMartinez-Lopez, Maria
dc.contributor.authorSoto, Manuel
dc.contributor.authorIborra, Salvador
dc.contributor.authorSancho, David
dc.contributor.funderMinisterio de Economía, Industria y Competitividad (España)
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderMinisterio de Educación, Cultura y Deporte (España)
dc.contributor.funderCentro Nacional de Investigaciones Cardiovasculares Carlos III (España)
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderFondation ACTERIA (Acting on European Research in Immunology and Allergology)
dc.contributor.funderAtresmedia
dc.contributor.funderFundación La Marató TV3
dc.contributor.funderUnión Europea. Comisión Europea
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderFundación ProCNIC
dc.date.accessioned2018-11-22T08:10:51Z
dc.date.available2018-11-22T08:10:51Z
dc.date.issued2018
dc.description.abstractProtozoan parasites of the Leishmania genus are the causative agents of leishmaniasis, a group of neglected tropical diseases whose clinical manifestations vary depending on the infectious Leishmania species but also on host factors. Recognition of the parasite by host myeloid immune cells is a key to trigger an effective Leishmania-specific immunity. However, the parasite is able to persist in host myeloid cells by evading, delaying and manipulating host immunity in order to escape host resistance and ensure its transmission. Neutrophils are first in infiltrating infection sites and could act either favoring or protecting against infection, depending on factors such as the genetic background of the host or the parasite species. Macrophages are the main host cells where the parasites grow and divide. However, macrophages are also the main effector population involved in parasite clearance. Parasite elimination by macrophages requires the priming and development of an effector Th1 adaptive immunity driven by specific subtypes of dendritic cells. Herein, we will provide a comprehensive outline of how myeloid cells regulate innate and adaptive immunity against Leishmania, and the mechanisms used by the parasites to promote their evasion and sabotage. Understanding the interactions between Leishmania and the host myeloid cells may lead to the development of new therapeutic approaches and improved vaccination to leishmaniases, an important worldwide health problem in which current therapeutic or preventive approaches are limited.
dc.description.peerreviewed
dc.description.sponsorshipSI is funded by grant SAF2015-74561-JIN from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) and FEDER (European Fund for Regional Development). MM-L received a FPU fellowship (AP2010-5935) from the Spanish Ministry of Education. Work in the DS laboratory is funded by the CNIC and grant SAF2016-79040-R from MINECO, Agencia Estatal de Investigacion and FEDER; B2017/BMD-3733 Immunothercan-CM from Comunidad de Madrid; RD16/0015/0018-REEM from FIS-Instituto de Salud Carlos III, MINECO and FEDER; Acteria Foundation; Constantes y vitales prize (Atresmedia); La Marato de TV3 Foundation (201723); the European Commission (635122-PROCROP H2020) and the European Research Council (ERC-2016-Consolidator Grant 725091). The CNIC is supported by the MINECO and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505).
dc.format.volume9
dc.identifierISI:000431480800001
dc.identifier.citationFront Microbiol. 2018; 9:883
dc.identifier.doi10.3389/fmicb.2018.00883
dc.identifier.issn1664-302X
dc.identifier.journalFRONTIERS IN MICROBIOLOGY
dc.identifier.pubmedID29867798
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6672
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/725091es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/635122es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2015-74561-JINes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEV-2015-0505es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/AP2010-5935es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2016-79040-Res_ES
dc.relation.publisherversionhttps://doi.org/10.3389/fmicb.2018.00883
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Inmunobiología
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMyeloid cell
dc.subjectLeishmania
dc.subjectImmune escape
dc.subjectNeutrophils
dc.subjectMacrophages
dc.subjectDendritic cells
dc.subjectNEUTROPHIL EXTRACELLULAR TRAPS
dc.subjectCD8(+) T-CELLS
dc.subjectMACROPHAGE IL-12 PRODUCTION
dc.subjectTYROSINE-PHOSPHATASE SHP-1
dc.subjectNITRIC-OXIDE SYNTHASE
dc.subjectHUMAN DENDRITIC CELLS
dc.subjectPROTEIN-KINASE-C
dc.subjectKINETOPLASTID MEMBRANE PROTEIN-11
dc.subjectDONOVANI PROMASTIGOTES EVADE
dc.subjectSUSCEPTIBLE BALB/C MICE
dc.titleLeishmania Hijacks Myeloid Cells for Immune Escape
dc.typejournal article
dspace.entity.typePublication
relation.isAuthorOfPublication2d6362e5-b9b7-474f-90f8-0d8e4abe6657
relation.isAuthorOfPublicatione2541003-e1a6-464d-8b2e-285ada6c18c4
relation.isAuthorOfPublication58aa2591-8084-4500-bfe4-8f2c54e398e9
relation.isAuthorOfPublication.latestForDiscovery2d6362e5-b9b7-474f-90f8-0d8e4abe6657
relation.isFunderOfPublication780d850b-a444-4474-ba4e-85ab2579d4ac
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication41383d53-27b2-4b36-a8d4-ead2ae8fe63b
relation.isFunderOfPublication13936dca-3040-4689-8cca-a0d0960a0c50
relation.isFunderOfPublication54733407-1d78-4c44-bf4c-8c8a7592aa4b
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication8c8cc7d5-d7a5-412a-a09f-a85f965dee8c
relation.isFunderOfPublication4d45263f-ecac-4a82-8126-24e358556e59
relation.isFunderOfPublicationff637ff5-6bbe-4cb4-917f-84200711c119
relation.isFunderOfPublication639cecfa-9455-4e7f-9f65-9ece17a878f0
relation.isFunderOfPublicationcb2ee04a-8d42-4a64-b3f6-3c156f222b35
relation.isFunderOfPublicationef935eeb-4c46-446a-868e-66e905683e75
relation.isFunderOfPublication.latestForDiscovery780d850b-a444-4474-ba4e-85ab2579d4ac
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
LeishmaniaHijacksMyeloidCells_2018.pdf
Size:
2.43 MB
Format:
Adobe Portable Document Format